Pages
Diabetes Education FAQs
Frequently Asked Questions about Diabetes and Diabetes Education for the people of Derby and Derbyshire
Sustainability/Green Agenda
https://dchs.nhs.uk/my_dchs/i-want-more-information-on/corporate-services/sustainabilitygreen-agenda
Warm Spaces opening at two Derbyshire community hospitals
https://dchs.nhs.uk/news/warm-spaces-opening-two-derbyshire-community-hospitals
A BIG conversation is about to begin… and you’re invited.
Join a generational first big conversation to shape how to improve your wellbeing working in the NHS.
Health Psychology - Information and Tools to Help You
A page of health psychology information and resources for the people of Derbyshire.
Information about your appointment
Everything you need to know before you attend a physiotherapy appointment at Derbyshire Community Health Services NHS FT
Diabetes Education Service
If you have type 2 diabetes, attending an education programme is an important part of your treatment plan.
Research and Innovation
Our vision is to increase capacity, capability and participation in research and innovation as we embed a culture of continuous improvement across the organisation.
Community podiatry - Our Services
Community podiatry services - what services are offered by DCHS community podiatry team
Files
North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance) (G198)
OPAT services provide intravenous (IV) antibiotics to patients outside of the acute hospital inpatient setting. Patients who are otherwise medically fit, and who would otherwise require a hospital bed, can avoid admission to hospital, or be discharged sooner by receiving treatment either as an outpatient or within their own homes. In North Derbyshire, this is achieved by Chesterfield Royal Hospital Foundation Trust (CRHFT) working in partnership with Derbyshire Community Health Services (DCHS) Rapid Response Team (RRT).
0501 - In-patient Care Plans
0501 - Inpatient Care Plan
Moisture Associated Skin Damage Barrier Film Pathway (G197)
Moisture Associated Skin Damage Barrier Film Pathway including MEDI DERMA-S Instructions for Use Guide
L29 - UTC Advice leaflet - Why an X-Ray may not be indicated
L29 - UTC Advice leaflet - Why an X-Ray may not be indicated
Tranexamic acid use in the Treatment of Malignant Fungating Wounds (G194)
Tranexamic acid use in the Treatment of Malignant Fungating Wounds
Risk Assessment Grading Matrix 5 x 5.doc
Risk assessment grading matrix - staff
Community Podiatry Service Welcome leaflet.pdf
DCHS Community Podiatry service - welcome leaflet
Appendix 6 - Information for DCHS Clinical Supervisor Live Register (P45)
Appendix 6 - Information for DCHS Clinical Supervisor Live Register (P45)
Data Protection Factsheet_1_-_Act_overview2018-05-23_.pdf
Date Protection factsheet
DCHS Mandatory training overview (V0.1) May 2022
Mandatory training overview (V0.1) May 2022